ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 359239 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 359239; 2) Community: the network communities that were significantly associated with the response to NSC 359239; 3) Molecule: the relationships between components within communities and NSC 359239; 4) MDR: the compounds that were significantly associated with the NSC 359239.

NSC Compound Enrichment Correlation
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.0164116791870034 0.070422806
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.0164116791870034 0.16536394
NSC 752703 Null 0.0164116791870034 -0.050080876
NSC 754118 6-chloro-7-phenyl-8-(3,5-dimethoxybenzyl)- 5,8-dihydro-4H-isoxazolo[4,5-g]indole 0.0164116791870034 0.082927388
NSC 755465 Null 0.0164116791870034 0.016558218
NSC 756209 GW296115X 0.0164116791870034 -0.020315371
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0164116791870034 0.20094325
NSC 759274 ARSENIC TRIOXIDE 0.0164116791870034 0.22879081
NSC 357704 Cyanomorpholinodoxorubicin 0.0164116791870036 0.13381113
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.0193573267900279 0.04520283
Total:74  Current:33    [First] [Prev] [Next] [Last]